Genetic modification of human T cells with CD20: A novel suicide system for the treatment of GVHD.

被引：0
|
作者：
Introna, M
Casati, C
Bambacioni, F
Gaipa, G
Golay, J
Rambaldi, A
Biondi, A
机构：
[1] Ist Ric Farmacol Mario Negri, Mol Immunohematol Lab, Milan, Italy
[2] Univ Milan Bicocca, Ctr Ric Fdn Tettamanti Cura Leucemie, Monza, Italy
[3] Osped Riuniti Bergamo, Div Hematol, I-24100 Bergamo, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
912
引用
收藏
页码：214A / 214A
页数：1
相关论文
共 50 条
  • [31] Characterization of a human bispecific antibody against CD20/CD55 for the treatment of burkitt lymphoma
    Macor, Paolo
    Mezzaroba, Nelly
    De Maso, Luca
    Garrovo, Chiara
    Biffi, Stefania
    Sblattero, Daniele
    Marzari, Roberto
    Tedesco, Francesco
    [J]. IMMUNOBIOLOGY, 2012, 217 (11) : 1149 - 1150
  • [32] Restoration of rituximab sensitivity in CD20 negative B-Cell lymphoma, cells; Epigenetic change of CD20 expression after treatment of rituximab.
    Tomita, Akihiro
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tornoki
    [J]. BLOOD, 2006, 108 (11) : 155B - 155B
  • [33] CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties
    Martijn Vlaming
    Vrouyr Bilemjian
    Jimena Álvarez Freile
    Harm Jan Lourens
    Nienke van Rooij
    Gerwin Huls
    Tom van Meerten
    Marco de Bruyn
    Edwin Bremer
    [J]. Scientific Reports, 11
  • [34] Optimization of methods for the genetic modification of human T cells
    Bilal, Mahmood Y.
    Vacaflores, Aldo
    Houtman, Jon C. D.
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2015, 93 (10): : 896 - 908
  • [35] CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties
    Vlaming, Martijn
    Bilemjian, Vrouyr
    Freile, Jimena Alvarez
    Lourens, Harm Jan
    van Rooij, Nienke
    Huls, Gerwin
    van Meerten, Tom
    de Bruyn, Marco
    Bremer, Edwin
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [36] Relationship Between Post-Translational Modification of CD20 Protein and the Responsiveness to Rituximab Treatment.
    Sugimoto, Takumi
    Tomita, Akihiro
    Shimada, Kazuyuki
    Hiraga, Junji
    Kiyoi, Hitoshi
    Kinoshita, Tomohiro
    Naoe, Tomoki
    [J]. BLOOD, 2008, 112 (11) : 922 - 922
  • [37] CD8+T cells expressing CD20 populate brain and cerebrospinal fluid in multiple sclerosis
    Blok, K.
    Engelenburg, J.
    Van Puijfelik, F.
    Hsiao, C.
    De Beukelaar, J.
    Wokke, B.
    Huitinga, I.
    Hamann, J.
    Smolders, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 229 - 229
  • [38] Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells
    Liu, Yanlong
    Ao, Kexin
    Bao, Fuxiang
    Cheng, Yi
    Hao, Yanxia
    Zhang, Huimin
    Fu, Shan
    Xu, Jiaqi
    Wu, Qiyao
    [J]. VACCINES, 2022, 10 (08)
  • [39] Features of Human CD3+CD20+ T Cells
    Schuh, Elisabeth
    Berer, Kerstin
    Mulazzani, Matthias
    Feil, Katharina
    Meinl, Ingrid
    Lahm, Harald
    Krane, Markus
    Lange, Ruediger
    Pfannes, Kristina
    Subklewe, Marion
    Guerkov, Robert
    Bradl, Monika
    Hohlfeld, Reinhard
    Kuempfel, Tania
    Meinl, Edgar
    Krumbholz, Markus
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 197 (04): : 1111 - 1117
  • [40] Human CD20 deficiency impairs the ability to mount T cell independent antibody responses
    Kuijpers, T. W.
    Bende, R.
    Derks, I
    Dolman, K. M.
    Beaumont, T.
    van Noesel, C. J. M.
    Eldering, E.
    van Lier, R. A. W.
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 : 14 - 14
12345